Lantern Pharma Faces 21 % Stock Decline Following Announcement of Financial Results Webcast
Lantern Pharma Inc, a leading artificial intelligence (AI) company specializing in targeted cancer therapies, announces its plan to host a webcast on Monday, March 18,
